期刊文献+

彩色多普勒高频超声结合CT检查在诊断乳腺恶性肿瘤中的价值 被引量:5

Value of High-Frequency Color Doppler Ultrasound Combined with CT for Breast Cancer Diagnosis
下载PDF
导出
摘要 目的探讨彩色多普勒高频超声结合CT在乳腺恶性肿瘤诊断中的临床价值。方法对我院曾经收治的58例乳腺恶性肿瘤患者的影像资料进行回顾分析,本组患者均经过彩色多普勒高频超声检查和CT检查,总结不同检查方法的图像特征,分析两种检查方法对于患者的检出率,寻找一种临床上针对乳腺恶性肿瘤患者能够有效检出的诊断方法。结果CT检查正确诊断共51例,符合率87.93%,彩色多普勒高频超声正确诊断共47例,符合率81.03%,联合应用两者诊断符合率达93.1%。结论彩色多普勒高频超声结合CT检查可以有效提高乳腺恶性肿瘤的检出率,为临床提供有效依据,值得推广。 Objective To explore the value of high-frequency color Doppler ultrasound combined with CT for breast cancer diagnosis.Methods Review 58 cases of breast cancer that were treated in our hospital.All of them were diagnosed by high-frequency color Doppler ultrasound and CT.Analysis characteristics of the image and the detection rate of the two methods.Looking for an effective clinical method for diagnosis of breast cancer.Results CT diagnosis of 51 cases,the accuracy was 87.93%,ultrasound diagnosis of 47 cases,the accuracy was 81.03%,combination of both diagnostic accuracy was 93.1%.Conclusion Combined with high-frequency color Doppler ultrasound and CT can improve breast cancer detection rate,worthy of promotion and application in clinical practice.
作者 傅俊明 欧鸿儒 贾红明 莫家彬 FU Jun-ming;OU Hong-ru;JIA Hong-ming;MO Jia-bin(Department of Imaging,Shunde Hospital Affiliated to Jinan University(the Second People's Hospital of Shunde District,Foshan City,Feng Yaojing Memorial Hospital,Shunde District,Foshan City),Shunde 528305,Guangdong Province,China)
出处 《罕少疾病杂志》 2022年第6期44-45,共2页 Journal of Rare and Uncommon Diseases
关键词 彩色多普勒 高频超声 CT 乳腺恶性肿瘤 Color Doppler High-Frequency Ultrasound CT Breast Cancer
  • 相关文献

参考文献7

二级参考文献54

  • 1李旭军.钼钯与超声检查对乳腺癌诊断灵敏度的比较[J].现代实用医学,2009,21(4). 被引量:4
  • 2李银珍,黄道中,赵胜,李进兵.乳腺癌肿瘤血管的多普勒超声研究[J].中国医学影像技术,2006,22(6):873-875. 被引量:25
  • 3Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med, 2000, 30(3): 150-185. 被引量:1
  • 4Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics, 2003, 23(2): 315-340; quiz 533. 被引量:1
  • 5Israel I, Mor M, Guralnik L, et al. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? J Nucl IVied, 2004, 45:2045-2051. 被引量:1
  • 6Oriuchi N, Higuchi T, Ishikita T, et al. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci, 2006, 97(12): 1291-1297. 被引量:1
  • 7Rosen EL, Eubank WB, MankoffDA. FDG PET, PET/CT, and breast cancer imaging. Radiographics, 2007, 27:S215-S229. 被引量:1
  • 8Avril N, Adler LP. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. Radiol Clin NorthAm, 2007, 45(4): 645-657, vi. 被引量:1
  • 9American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston, VA: American College of Radiology, 2003. 被引量:1
  • 10Cheng JY, Lei L, Xu JY, et al. 18F-fluoromisonidazole PET/ CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer. J Nucl Med, 2013, 54(3): 333-340. 被引量:1

共引文献57

同被引文献66

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部